Michael Best’s autotaxin inhibitor may become a key weapon in the fight against cancer.
Michael Best
Michael Best
Recognizing Michael Best for his NSF CAREER Award to advance his research on cell surface protein binding.
Research, Scholarship, and Creative Activity at the University of Tennessee, Knoxville